{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:41Z","timestamp":1786986881652,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cll.2025.07.003","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:15:24Z","timestamp":1757452524000},"page":"601-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["von Willebrand Disease and von Willebrand Factor"],"prefix":"10.1016","volume":"45","author":[{"given":"Bailey","family":"Hutchison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Podd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Haberichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2025.07.003_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol"},{"key":"10.1016\/j.cll.2025.07.003_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"issue":"13","key":"10.1016\/j.cll.2025.07.003_bib3","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","article-title":"von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends","volume":"125","author":"Lenting","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2025.07.003_bib4","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1182\/blood.V96.5.1808","article-title":"von Willebrand factor storage and multimerization: 2 independent intracellular processes","volume":"96","author":"Haberichter","year":"2000","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cll.2025.07.003_bib5","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1073\/pnas.84.7.1955","article-title":"Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells","volume":"84","author":"Wagner","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2025.07.003_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jth.12225","article-title":"The secretion of von Willebrand factor from endothelial cells; an increasingly complicated story","volume":"11","author":"Nightingale","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.cll.2025.07.003_bib7","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V88.8.2951.bloodjournal8882951","article-title":"Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans","volume":"88","author":"Borchiellini","year":"1996","journal-title":"Blood"},{"issue":"Suppl 3","key":"10.1016\/j.cll.2025.07.003_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2516.1998.0040s3033.x","article-title":"Pharmacokinetics, efficacy and safety of Humate-P in von Willebrand disease","volume":"4","author":"Dobrkovska","year":"1998","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.cll.2025.07.003_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2141.2008.07311.x","article-title":"Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease","volume":"143","author":"Sztukowska","year":"2008","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.cll.2025.07.003_bib10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1365-2141.1996.d01-1860.x","article-title":"Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study Groups","volume":"94","author":"Menache","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cll.2025.07.003_bib11","series-title":"Hemostasis and thrombosis: basic principles and clinical practice","first-page":"134","article-title":"CBS. von Willebrand disease","author":"Montgomery","year":"1994"},{"issue":"1","key":"10.1016\/j.cll.2025.07.003_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.cll.2025.07.003_bib13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.cll.2025.07.003_bib14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/hematology.2019000064","article-title":"New advances in the diagnosis of von Willebrand disease","volume":"2019","author":"Sharma","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"8","key":"10.1016\/j.cll.2025.07.003_bib15","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jtha.2024.05.006","article-title":"Application of genetic testing for the diagnosis of von Willebrand disease","volume":"22","author":"Seidizadeh","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.cll.2025.07.003_bib16","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/jth.12964","article-title":"Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH","volume":"13","author":"Bod\u00f3","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.cll.2025.07.003_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2009-10-249102","article-title":"Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor","volume":"116","author":"Flood","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2025.07.003_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0037-1613765","article-title":"A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor","volume":"83","author":"Vanhoorelbeke","year":"2000","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.cll.2025.07.003_bib19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/MBC.0000000000000169","article-title":"Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin","volume":"25","author":"Patzke","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"10.1016\/j.cll.2025.07.003_bib20","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1182\/blood-2010-08-299016","article-title":"Gain-of-function GPIb ELISA assay for VWF activity in the zimmerman program for the molecular and clinical biology of VWD","volume":"117","author":"Flood","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2025.07.003_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102422","article-title":"Evaluation of an automated von Willebrand factor glycoprotein IbM activity assay compared with 3 alternative von Willebrand factor activity assays","volume":"8","author":"Friedman","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"12","key":"10.1016\/j.cll.2025.07.003_bib22","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/jth.14319","article-title":"Clinically relevant differences between assays for von Willebrand factor activity","volume":"16","author":"Boender","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.cll.2025.07.003_bib23","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1538-7836.2010.03869.x","article-title":"Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD","volume":"8","author":"Flood","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"14","key":"10.1016\/j.cll.2025.07.003_bib24","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood-2014-11-610824","article-title":"Crucial role for the VWF A1 domain in binding to type IV collagen","volume":"125","author":"Flood","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2025.07.003_bib25","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1111\/hae.13261","article-title":"Evaluation of a new commercial von Willebrand factor multimer assay","volume":"23","author":"Favaloro","year":"2017","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.cll.2025.07.003_bib26","first-page":"1127","article-title":"Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease--single center comparison of four different assays","volume":"84","author":"Federici","year":"2000","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.cll.2025.07.003_bib27","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1373\/clinchem.2012.199000","article-title":"Collagen binding provides a sensitive screen for variant von Willebrand disease","volume":"59","author":"Flood","year":"2013","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.cll.2025.07.003_bib28","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1111\/j.1538-7836.2006.02069.x","article-title":"von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M","volume":"4","author":"Baronciani","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.cll.2025.07.003_bib29","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cll.2025.07.003_bib30","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2025.07.003_bib31","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jtha.2023.01.012","article-title":"Genetic determinants of enhanced von Willebrand factor clearance from plasma","volume":"21","author":"Seidizadeh","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.cll.2025.07.003_bib32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1182\/bloodadvances.2022007340","article-title":"Enhanced VWF clearance in low VWF pathogenesis: limitations of the VWFpp\/VWF:Ag ratio and clinical significance","volume":"7","author":"Doherty","year":"2023","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.cll.2025.07.003_bib33","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"19","key":"10.1016\/j.cll.2025.07.003_bib34","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIII\/von Willebrand factor in a new subtype of von Willebrand\u2019s disease","volume":"302","author":"Ruggeri","year":"1980","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cll.2025.07.003_bib35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJM198202113060603","article-title":"Pseudo-von Willebrand\u2019s disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII\/Von willebrand factor and enhanced adsorption of its high-molecular-weight multimers","volume":"306","author":"Weiss","year":"1982","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.cll.2025.07.003_bib36","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1538-7836.2008.02945.x","article-title":"Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)","volume":"6","author":"Budde","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.cll.2025.07.003_bib37","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1538-7836.2006.01823.x","article-title":"Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD","volume":"4","author":"Eikenboom","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.cll.2025.07.003_bib38","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood.V66.6.1423.1423","article-title":"High-resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand disease with aberrant structure but presence of all size multimers (type IC)","volume":"66","author":"Ciavarella","year":"1985","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2025.07.003_bib39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1538-7836.2009.03290.x","article-title":"Genetic alteration of the D2 domain abolishes von Willebrand factor multimerization and trafficking into storage","volume":"7","author":"Haberichter","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.cll.2025.07.003_bib40","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1309\/AJCPH5JK4ONENPAE","article-title":"Von Willebrand factor assay proficiency testing. The North American Specialized Coagulation Laboratory Association experience","volume":"135","author":"Chandler","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.cll.2025.07.003_bib41","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ajh.21739","article-title":"Analysis of von Willebrand factor structure by multimer analysis","volume":"85","author":"Ledford-Kraemer","year":"2010","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.cll.2025.07.003_bib42","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.thromres.2010.09.015","article-title":"Plasma von Willebrand factor multimer quantitative analysis by in-gel immunostaining and infrared fluorescent imaging","volume":"126","author":"Pruthi","year":"2010","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.cll.2025.07.003_bib43","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1309\/AJCPZSBTD2BWOMVL","article-title":"Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detection","volume":"133","author":"Ott","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.cll.2025.07.003_bib44","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1309\/75CQ-V7UX-4QX8-WXE7","article-title":"Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry","volume":"116","author":"Studt","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.cll.2025.07.003_bib45","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000542","article-title":"Von Willebrand Factor Multimer Densitometric Analysis: validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease","volume":"5","author":"Boender","year":"2021","journal-title":"Hemasphere"},{"issue":"21","key":"10.1016\/j.cll.2025.07.003_bib46","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1182\/blood.V118.21.1215.1215","article-title":"Quantitative analysis of VWF multimer structure: discrimination between VWD subtypes","volume":"118","author":"Haberichter","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cll.2025.07.003_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22416","article-title":"Preclinical evaluation of a semi-automated and rapid commercial electrophoresis assay for von Willebrand factor multimers","volume":"32","author":"Pikta","year":"2018","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"10.1016\/j.cll.2025.07.003_bib48","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/rth2.12141","article-title":"Evaluation of a semi-automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers","volume":"2","author":"Bowyer","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"5","key":"10.1016\/j.cll.2025.07.003_bib49","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/ijlh.12869","article-title":"Evaluation of a new commercial method for von Willebrand factor multimeric analysis","volume":"40","author":"Crist","year":"2018","journal-title":"Int J Lab Hematol"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271225000575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271225000575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T02:23:19Z","timestamp":1761618199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271225000575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0272271225000575"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2025.07.003","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"von Willebrand Disease and von Willebrand Factor","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2025.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}